Latest Form 4 insider transactions

NASDAQ
Zain Syed Hasan, Chief Growth Officer of Health In Tech, Inc., reported a transaction in 4,007 shares of common stock on August 13, 2026.
AMEX
Brian S Olschan, President and COO and a Director of Acme United Corp, reported multiple transactions in common stock on August 13, 2026.
NASDAQ
Bruce Kenneth Hounsell, President, Heritage DebtX LLC of Heritage Global Inc., purchased 10,000 shares of common stock on August 17, 2026 for $1.14 per share.
NYSE
Jonathan Wade Lyall, EVP Sales/Business Development of Champion Homes, Inc., reported a transaction in 1,804 shares of common stock on August 15, 2026.
NYSE
Martha A Tirinnanzi, a Director of Intercontinental Exchange, Inc., sold 141 shares of common stock on August 13, 2026 for $155.00 per share.
NASDAQ
Leonardo Viana Nicacio, Chief Medical Officer of Corbus Pharmaceuticals Holdings, Inc., reported multiple transactions in common stock on August 16, 2026.
NYSE
Laurel Krueger, CLO & Secretary of Champion Homes, Inc., reported a transaction in 1,356 shares of common stock on August 15, 2026.
OQB
David J. Douglas, a Director and 10% owner of Koil Energy Solutions, Inc., reported multiple transactions in common stock on August 11, 2026.
NYSE
Christine M Cumming, a Director of Citizens Financial Group Inc/Ri, received 269 shares of common stock on August 13, 2026.
NYSE
Michele N Siekerka, a Director of Citizens Financial Group Inc/Ri, received 134 shares of common stock on August 13, 2026.
NYSE
Theresa A Shaw, SVP and CATO of Ameren Corp, sold 325 shares of common stock on August 14, 2026 for $108.93 per share.
NASDAQ
Lawrence Michael Ziemba, a Director of Plains Gp Holdings Lp, reported multiple transactions in common stock on August 13, 2026.
NYSE
Robert G Leary, a Director of Citizens Financial Group Inc/Ri, received 208 shares of common stock on August 13, 2026.
NYSE
Edward J Kelly Iii, a Director of Citizens Financial Group Inc/Ri, received 246 shares of common stock on August 13, 2026.
NYSE
Christopher Swift, a Director of Citizens Financial Group Inc/Ri, purchased 30 shares of common stock on February 6, 2024.
NASDAQ
Anthony R Chase, a Director of National Energy Services Reunited Corp., reported multiple transactions in common stock on August 14, 2026.
NYSE
Marita Zuraitis, a Director of Citizens Financial Group Inc/Ri, received 269 shares of common stock on August 13, 2026.
NYSE
Claude E. Wade, a Director of Citizens Financial Group Inc/Ri, received 47 shares of common stock on August 13, 2026.
NASDAQ
Cindy B Taylor, a Director of Plains Gp Holdings Lp, received 7,700 shares of common stock on August 13, 2026.
NASDAQ
K Gary Barnette, Chief Scientific Officer of Veru Inc., purchased 1,800 shares of common stock on August 13, 2026 for $2.69 per share.
NASDAQ
Benjamin Richard Wheeler, Chief Financial Officer of Myriad Genetics Inc, reported a transaction in 8,761 shares of common stock on August 16, 2026.
NASDAQ
Charles J. Prober, a Director of Life360, Inc., sold 7,930 shares of common stock on August 13, 2026 for $48.59 per share.
NASDAQ
Mejia Antonio J Campo, a Director of National Energy Services Reunited Corp., reported multiple transactions in common stock on August 14, 2026.
NASDAQ
Bobby S Shackouls, a Director of Plains Gp Holdings Lp, reported multiple transactions in common stock on August 13, 2026.
NYSE
Laurida Sayed, See Remarks of Cushman & Wakefield plc, sold 16,000 shares of common stock on August 13, 2026 for $13.88 per share.
NASDAQ
Fulcrum Therapeutics and Slate Medicines announce a definitive agreement to combine in an all-stock transaction, creating Slate Medicines, Inc. with a $245 million private placement.
NASDAQ
Kevin D Miller, CFO of Rcm Technologies, Inc., received 8,362 shares of common stock on August 13, 2026.
NASDAQ
Elizabeth W Vanderslice, a Director of Advanced Micro Devices Inc, reported multiple transactions in common stock on August 13, 2026.
NASDAQ
Stefan Angeli, Chief Financial Officer of National Energy Services Reunited Corp., reported multiple transactions in common stock on March 16, 2026.
NASDAQ
Stacy Lindborg, President and CEO and a Director of Imunon, Inc., received 6,615 shares of common stock on August 14, 2026.